Cannes is back: The 78th French film festival returns May 13-24 with a wave of world premieres that will set the tone for the ...

Blue Bird is well-positioned to benefit from long-term tailwinds for the electric bus industry, despite regulatory headwinds.

Russia has reportedly complained to the U.S. in connection to the strikes on its energy infrastructure by Ukraine in the last ...

We recently compiled a list of the 10 Best EV Stocks to Buy Under $50. In this article, we are going to take a look at where ...

Tensions rise as Egypt’s military buildup in Sinai sparks Israeli concerns over a possible peace deal violation. Israeli ...

It’s a bird, it’s a plane, it’s the future!Don't Miss Our End of Quarter Offers: Discover the latest stocks recommended by top Wall Street ...

In a report released on March 28, Gena Wang from Barclays maintained a Buy rating on Bluebird Bio (BLUE – Research Report), with a price target ...

This shot of a pair of courting crab spiders, taken by nature photographer Sandip Guha in Shiliguri, India, highlights the ...

An initiative in Zambia is showing that a profit-seeking company can help rural farmers battling extreme weather breed chickens that lay more eggs.

In the most recent development in the billionaire's swift consolidation of power, Elon Musk's xAI artificial intelligence ...

The new bid surpasses an offer SK Capital and Carlyle Group made last month for the gene therapy developer, which Bluebird’s ...

Gene therapy maker bluebird bio said on Friday it had received a non-binding offer from peer Ayrmid for up to $110.5 million, sending its shares up 9.8% at $4.40 in extended trading.